8-K//Current report
Unicycive Therapeutics, Inc. 8-K
Accession 0001213900-25-111045
$UNCYCIK 0001766140operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:10 PM ET
Size
257.8 KB
Accession
0001213900-25-111045
Documents
- 8-Kea0265675-8k_unicycive.htmPrimary
CURRENT REPORT
- EX-1.1ea026567502ex1-1_unicycive.htm
AMENDMENT NO. 1 TO SALES AGREEMENT, DATED NOVEMBER 14, 2025, BETWEEN UNICYCIVE THERAPEUTICS, INC. AND GUGGENHEIM SECURITIES, LLC
- EX-5.1ea026567502ex5-1_unicycive.htm
OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP
- GRAPHICex5-1_001.jpg
GRAPHIC
- EX-101.SCHuncy-20251114.xsd
XBRL SCHEMA FILE
- EX-101.LABuncy-20251114_lab.xml
XBRL LABEL FILE
- EX-101.PREuncy-20251114_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-111045-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0265675-8k_unicycive_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Unicycive Therapeutics, Inc.
CIK 0001766140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001766140
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:10 PM ET
- Size
- 257.8 KB